NEWS
View news from our Featured Companies.
PolyPid to Report Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights on February 9, 2022
PETACH TIKVA, Israel, Jan. 26, 2022 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a Phase 3 biopharmaceutical company focused on developing targeted, locally administered, and prolonged-release therapeutics using its proprietary PLEX technology, today...
LiqTech Signs OEM Membrane Sales Supply Agreement
Total Revenues Expected to Exceed $23 million3-Year OEM Membrane Supply Agreement. Expected to Commence Deliveries in Q3 2022 Addressing Global Drinking Water IndustryBALLERUP, Denmark, Jan. 26, 2022 -- LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean...
Columbus, Ohio Joins a Growing Number of Cities Across the United States Deploying SenesTech’s ContraPest® as Part of Their Pest Management Programs
PHOENIX, Jan. 25, 2022 -- SenesTech (NASDAQ: SNES) (www.senestech.com), the rodent fertility control expert, announced today that Columbus, Ohio is the latest city to begin using ContraPest®. Columbus now joins cities like San Francisco, Washington DC, Hartford,...
ChromaDex Announces Results of New Pilot Clinical Trial Showing Anti-Inflammatory Effects of Nicotinamide Riboside (NR) Supplementation
Researchers publish new clinical data on NR supplementation, marking the 18th clinical trial on ChromaDex's Niagen® ingredient LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) today announced results of the 18th clinical trial on its flagship Niagen® (patented...
Los Angeles County To Require Rat Fertility Control be Part of its Pest Management Program Moving Forward as it Works to Combat Soaring Rat Populations
SenesTech's ContraPest® is the only EPA registered fertility control product for ratsPHOENIX, Jan. 21, 2022 -- SenesTech (NASDAQ: SNES) (www.senestech.com), the rodent fertility control expert, noted today that Los Angeles County, one of the largest counties in...
IRADIMED CORPORATION to Hold 2021 Fourth Quarter Financial Results Conference Call on February 4th
WINTER SPRINGS, Fla., Jan. 20, 2022 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 fourth quarter financial results before the market opens on Friday, February 4th. IRADIMED management will host a conference call the same...
ChromaDex and Designs for Health Partner for New Product Development on Niagen®
ChromaDex announces supply agreement with Designs for Health, offering new Niagen®-formulated products LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) today announced a supply agreement with Designs for Health, a U.S.-based manufacturer of premium dietary supplements...
Jewett-Cameron Announces 1st Quarter Financial Results
NORTH PLAINS, Ore., Jan. 14, 2022 -- Jewett-Cameron Trading Company Ltd. (NASDAQ: JCTCF) today reported financial results for the first quarter of fiscal 2022 ended November 30, 2021. Sales for the first quarter of fiscal 2022 totaled $12.9 million compared to sales...
Mogo to Participate in BTIG Metaverse Unbound Conference
VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), a digital payments and financial technology company, today announced that Greg Feller, President, will be participating in the BTIG Metaverse Unbound Conference, which is being...
InfuSystem to Present at Sidoti Winter Virtual Investor Conference on Wednesday, January 19, 2022
Investor Presentation to be held at 8:30 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
Mogo Appoints Senior Tech Executive as Chief People Officer
Former executive of US fintech leader, SoFi, and e-commerce pioneer, Amazon VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), a digital payments and financial technology company, today announced the appointment of highly...
Mogo Announces Expansion into Metaverse with Investment in NFT Trading Platform NFT Trader
Company operates global peer-to-peer non-fungible token trading platform that generated over US$50M of trading volume in last 30 days Mogo acquires an initial 25% with fixed-price option to increase to 50% VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO)...
Reviva Pharmaceuticals Holdings, Inc. Receives FDA May Proceed Letter for Pivotal Phase 3 Clinical Trial and Long-Term Safety Trial Evaluating Brilaroxazine For The Treatment of Schizophrenia
- Brilaroxazine is a novel serotonin and dopamine receptor modulator currently being developed for diseases with dysfunctional serotonin signaling including neuropsychiatric and pulmonary indications - - Initiation of both Phase 3 trials is expected by end of January...
ImmuCell Announces Record Preliminary, Unaudited Sales Results for the Year Ended December 31, 2021
PORTLAND, Maine, Jan. 05, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
Kiora Pharmaceuticals to Provide 2022 Business Outlook at the H.C. Wainwright Bioconnect Virtual Conference
Salt Lake City, Utah--(January 5, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) will participate in the H.C. Wainwright Bioconnect Virtual Conference January 10-13, 2022. Brian Strem, Ph.D., President and Chief Executive Officer, will provide an outlook for the...
PolyPid Appoints UCSF Brain Tumor Center Director Mitchel S. Berger, M.D., to Oncology Advisory Board
Dr. Berger Brings Extensive Expertise in Deep Brain Tumor Treatment The Company Expects to Initiate a Phase 1/2 Clinical Trial of OncoPLEX for Brain Tumors by the end of 2022 PETAH TIKVA, Israel, Jan. 04, 2022 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the...
Aytu BioPharma Appoints Mark Oki as Chief Financial Officer
ENGLEWOOD, CO / January 4, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, today announced that Mark Oki will join Aytu as the company's chief financial officer...
PolyPid Announces Planned CEO Transition
Current EVP & CFO, Dikla Czaczkes Akselbrad, Appointed CEO, Effective July 2022PETAH TIKVA, Israel, Jan. 03, 2022 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a Phase 3 biopharmaceutical company focused on developing targeted, locally administered,...
Aytu BioPharma to Present at H.C. Wainwright BioConnect Conference
ENGLEWOOD, CO / January 3, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, today announced that Josh Disbrow, chief executive officer of Aytu, will present a...
Zoomd Technologies Grants Stock Options
VANCOUVER, BC, Dec. 30, 2021 /CNW/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) ("Zoomd" or the "Company"), a leading provider of an online advertising robust marketing platform that focuses on improving customers user acquisition campaigns, announces that it...
Mogo Launches MogoTrade Commission-Free Stock Trading App
Canada's only commission-free app with free real-time streaming quotes Marks Mogo's entry into Canada's fast-growing market for commission-free trading VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), a digital payments and...
Mogo Receives Final Regulatory Approval for Launch of MogoTrade
Commission-free stock trading app to launch imminently VANCOUVER, British Columbia - Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ("Mogo" or the "Company"), a digital payments and financial-technology company, today announced it has received final approval from the Investment...
Reviva Pharmaceuticals to Participate in the Upcoming January Virtual Investor Conferences
CUPERTINO, Calif., Dec. 20, 2021 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
Mogo Expands Credit Facility and Lowers Interest Rate
VANCOUVER, British Columbia - Mogo Inc. (TSX:MOGO) (NASDAQ:MOGO) ("Mogo" or the "Company"), one of Canada's leading financial technology companies, today announced amendments to its existing senior credit facility ("Credit Facility") with funds managed by affiliates...
INVO Bioscience Enters into Agreement with Ovoclinic in Spain to Expand INVOcell Commercialization
Agreement follows initial utilization of INVOcell by Ovoclinic phyisicians in early 2021, resulting in successful patient experiences and outcomesOvoclinic will expand use of INVOcell in all four of their clinics and become the Center of Excellence and Training Site...